NFA
ASXC

Nationwide Fund Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

Nationwide Fund Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,106
Closed -$49K – 3277
2017
Q1 		$49K Sell
3,106
-598
-16% -$10.4K ﹤0.01% 2986
2016
Q4 		$63K Buy
3,704
+617
+20% +$12.6K ﹤0.01% 2974
2016
Q3 		$68K Sell
3,087
-1,762
-36% -$32.2K ﹤0.01% 2998
2016
Q2 		$77K Buy
4,849
+2,820
+139% +$88.5K ﹤0.01% 3004
2016
Q1 		$128K Hold
2,029
– – ﹤0.01% 2727
2015
Q4 		$65K Hold
2,029
– – ﹤0.01% 2949
2015
Q3 		$60K Buy
2,029
+271
+15% +$10K ﹤0.01% 3004
2015
Q2 		$69K Buy
1,758
+198
+13% +$9.12K ﹤0.01% 3077
2015
Q1 		$59K Sell
1,560
-145
-9% -$5.47K ﹤0.01% 3076
2014
Q4 		$64K Buy
1,705
+37
+2% +$1.53K ﹤0.01% 3002
2014
Q3 		$95K Hold
1,668
– – ﹤0.01% 3002
2014
Q2 		$109K Buy
+1,668
New +$96.3K ﹤0.01% 2998

Other funds holding ASXC

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nationwide Fund Advisors's ASXC Position: Q2 2017 in Review

Nationwide Fund Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q2 2017, closing a stake of 3,106 shares — an estimated $49K sold.

Nationwide Fund Advisors first reported a position in ASXC in Q2 2014 and held it in 12 quarters. The position peaked at $128K in Q1 2016. 67 funds tracked by Wall St. Rank hold ASXC as of Q2 2017.

  • Nationwide Fund Advisors reported no remaining Asensus Surgical, Inc. position as of Q2 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 3,106 Asensus Surgical, Inc. shares in Q2 2017, an estimated $49K.
  • Nationwide Fund Advisors first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 12 quarters.
  • Nationwide Fund Advisors's Asensus Surgical, Inc. position peaked at $128K in Q1 2016.
  • 67 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2017.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.